Differential Receipt of Genetic Services Among Patients With Gynecologic Cancer and Their Relatives: A Review of Challenges to Health Equity

Clin Obstet Gynecol. 2024 Dec 1;67(4):666-671. doi: 10.1097/GRF.0000000000000893. Epub 2024 Sep 27.

Abstract

Up to 14% of endometrial cancers and 23% of epithelial ovarian cancers are associated with genetic predispositions. Referral for genetic testing and counseling can significantly impact a patient's oncologic outcomes. However, significant disparities in genetic referral and testing exist within medically underserved and minority populations in the United States. These disparities in care and access to care are multifactorial, often involving patient-level, health care-level, and system-level factors. In this review, we focus on disparities in genetic testing among patients with ovarian and uterine cancer, and the missed opportunities for primary cancer prevention among their relatives.

Publication types

  • Review

MeSH terms

  • Endometrial Neoplasms / genetics
  • Endometrial Neoplasms / therapy
  • Female
  • Genetic Counseling
  • Genetic Predisposition to Disease
  • Genetic Testing* / methods
  • Genital Neoplasms, Female / genetics
  • Genital Neoplasms, Female / therapy
  • Health Equity*
  • Health Services Accessibility
  • Healthcare Disparities*
  • Humans
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / therapy
  • Referral and Consultation
  • United States
  • Uterine Neoplasms / genetics
  • Uterine Neoplasms / therapy